Meiliana Tjandra

This inventor holds 10 USPTO granted patents and 15 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: 10X Genomics, Inc., Novartis Ag. Active years: 2015-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Meiliana Tjandra. Retrieved from https://idiyas.com/inventor/meiliana-tjandra

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 15)

% Patents Active = 80.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 11)

Average Co-Inventor Count = 7.2

ph-index = 3

Forward Citations = 68(Granted Patents)

Location History:

Walnut Creek, CA (US) (2015)
Dublin, CA (US) (2015 - 2019)

Company Filing History:

Years Active: 2015-2026

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12516369 - Catalytic de-crosslinking of samples for in situ analysis (2026-01-06),

2. 12258624 - Catalytic de-crosslinking of samples for in situ analysis (2025-03-25),

3. 12241890 - Methods for generating barcoded nucleic acid molecules using fixed cells (2025-03-04),

4. 12234507 - Compositions and methods for targeted masking of autofluorescence (2025-02-25),

5. 12209273 - Nucleic acid assays using click chemistry bioconjugation (2025-01-28),

6. 12117439 - Compositions and methods for using fixed biological samples (2024-10-15),

7. 10369138 - Monobactam organic compounds for the treatment of bacterial infections (2019-08-06),

8. 9566312 - Cyclic peptides and use as medicines (2017-02-14),

9. 9174978 - Monobactam organic compounds for the treatment of bacterial infections (2015-11-03),

10. 9072696 - Cyclic peptides and use as medicines (2015-07-07),

Title: Meiliana Tjandra: Innovator in Biological Sample Analysis

Introduction

Meiliana Tjandra is a prominent inventor based in Dublin, CA (US). She has made significant contributions to the field of biological sample analysis, holding a total of 10 patents. Her work focuses on innovative methods and compositions that enhance the analysis of biological samples.

Latest Patents

Among her latest patents is a groundbreaking method titled "Catalytic de-crosslinking of samples for in situ analysis." This patent relates to methods and compositions that facilitate in situ analysis through catalytic de-crosslinking of biological samples. Another notable patent is "Methods for generating barcoded nucleic acid molecules using fixed cells." This disclosure provides compositions and methods for utilizing fixed biological samples in partition-based assays, including un-fixing agent compounds that can cleave crosslinks in fixed biological samples, particularly in crosslinked nucleic acids like RNA.

Career Highlights

Meiliana has worked with leading companies in the biotechnology sector, including 10x Genomics, Inc. and Novartis AG. Her experience in these organizations has allowed her to develop and refine her innovative approaches to biological analysis.

Collaborations

Throughout her career, Meiliana has collaborated with talented individuals such as Aregahegn Yifru and Joshua Delaney. These collaborations have contributed to her success and the advancement of her research.

Conclusion

Meiliana Tjandra is a trailblazer in the field of biological sample analysis, with a strong portfolio of patents and a history of impactful collaborations. Her work continues to influence the landscape of biological research and analysis.

Profile summary based on public USPTO records.